This review highlights the multifactorial mechanisms underlying platelet hyperreactivity in diabetes mellitus, which contributes to their high risk of atherothrombotic events.
Answers are grounded in this paper and cite their sources.
Multifactorial platelet dysfunction supports cautious antithrombotic strategies in diabetes; leaves open dominant pathways for targeted trials.
Patients with diabetes mellitus (DM) have accelerated atherosclerosis, which is the main underlying factor contributing to the high risk of atherothrombotic events in these patients. Atherothrombotic complications are the leading cause of morbidity and mortality in patients with DM. Among factors contributing to the prothrombotic condition which characterise patients with DM, platelet hyperreactivity plays a pivotal role. Platelets of DM patients are characterised by dysregulation of several signalling pathways leading to intensified adhesion, activation and aggregation. Multiple mechanisms are involved in platelet dysfunction of patients with DM, which can be categorised as follows: a) hyperglycaemia, b) insulin deficiency and resistance, c) associated metabolic conditions, and d) other cellular abnormalities.The present manuscript aims to provide an overview on the current status of knowledge on platelet abnormalities that characterise patients with DM.
No takes yet. Share an insight, caveat, or question.
Ferreiro et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: